Gemcitabine induces Epithelial-to-Mesenchymal Transition in patient-derived pancreatic ductal adenocarcinoma xenografts.
暂无分享,去创建一个
E. Van Cutsem | C. Verslype | L. Libbrecht | D. Nittner | J. van Pelt | J. Dekervel | Ashenafi Bulle | Lise Deschuttere | D. Lambrecht | David Nittner
[1] R. Pai,et al. Pathologic assessment of gastrointestinal tract and pancreatic carcinoma after neoadjuvant therapy , 2018, Modern Pathology.
[2] K. Lillemoe,et al. Tumor engraftment in patient-derived xenografts of pancreatic ductal adenocarcinoma is associated with adverse clinicopathological features and poor survival , 2017, PloS one.
[3] C. Jeffery,et al. Disruption of the monocarboxylate transporter-4-basigin interaction inhibits the hypoxic response, proliferation, and tumor progression , 2017, Scientific Reports.
[4] B. Jenkins,et al. Endoscopic ultrasound‐guided fine‐needle aspirate‐derived preclinical pancreatic cancer models reveal panitumumab sensitivity in KRAS wild‐type tumors , 2017, International journal of cancer.
[5] Farid G Khalafalla,et al. Inflammation and Epithelial-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma: Fighting Against Multiple Opponents , 2017, Cancer growth and metastasis.
[6] J. Qi,et al. Gene expression profiling of patient‐derived pancreatic cancer xenografts predicts sensitivity to the BET bromodomain inhibitor JQ1: implications for individualized medicine efforts , 2017, EMBO molecular medicine.
[7] D. Lambrechts,et al. Acriflavine Inhibits Acquired Drug Resistance by Blocking the Epithelial-to-Mesenchymal Transition and the Unfolded Protein Response , 2016, Translational oncology.
[8] C. Pilarsky,et al. The EMT-activator Zeb 1 is a key factor for cell plasticity and promotes metastasis in 1 pancreatic cancer 2 , 2017 .
[9] Maolin Yan,et al. Hypoxia induces TWIST-activated epithelial-mesenchymal transition and proliferation of pancreatic cancer cells in vitro and in nude mice. , 2016, Cancer letters.
[10] D. Lambrechts,et al. Successful application of endoscopic ultrasound-guided fine needle biopsy to establish pancreatic patient-derived tumor xenografts: a pilot study , 2016, Endoscopy.
[11] S. Aerts,et al. Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma , 2016, BMC Cancer.
[12] T. Christoffersen,et al. The TGFβ-SMAD3 pathway inhibits IL-1α induced interactions between human pancreatic stellate cells and pancreatic carcinoma cells and restricts cancer cell migration , 2016, Journal of Experimental & Clinical Cancer Research.
[13] S. Detlefsen,et al. Key players in pancreatic cancer-stroma interaction: Cancer-associated fibroblasts, endothelial and inflammatory cells. , 2016, World journal of gastroenterology.
[14] Jianghong Wu,et al. Transcriptional repression of SOCS3 mediated by IL-6/STAT3 signaling via DNMT1 promotes pancreatic cancer growth and metastasis , 2016, Journal of Experimental & Clinical Cancer Research.
[15] V. LeBleu,et al. EMT Program is Dispensable for Metastasis but Induces Chemoresistance in Pancreatic Cancer , 2015, Nature.
[16] T. Arumugam,et al. Animal Models of Gastrointestinal and Liver Diseases. The difficulty of animal modeling of pancreatic cancer for preclinical evaluation of therapeutics. , 2015, American journal of physiology. Gastrointestinal and liver physiology.
[17] J. Banyard,et al. The role of EMT and MET in cancer dissemination , 2015, Connective tissue research.
[18] S. Takao,et al. Slug contributes to gemcitabine resistance through epithelial-mesenchymal transition in CD133+ pancreatic cancer cells , 2015, Human Cell.
[19] K. Olive. Stroma, Stroma Everywhere (Far More Than You Think) , 2015, Clinical Cancer Research.
[20] A. Cress,et al. Gemcitabine resistant pancreatic cancer cell lines acquire an invasive phenotype with collateral hypersensitivity to histone deacetylase inhibitors , 2015, Cancer biology & therapy.
[21] Jer‐Yuh Liu,et al. Antitumor activity of acriflavine in lung adenocarcinoma cell line A549. , 2014, Anticancer research.
[22] E. Giovannetti,et al. Molecular Mechanisms Underlying the Role of MicroRNAs in the Chemoresistance of Pancreatic Cancer , 2014, BioMed research international.
[23] S. Sivanand,et al. Inhibition of hypoxia-inducible factors limits tumor progression in a mouse model of colorectal cancer. , 2014, Carcinogenesis.
[24] M. Ychou,et al. Tumour-stroma interactions in pancreatic ductal adenocarcinoma: rationale and current evidence for new therapeutic strategies. , 2014, Cancer treatment reviews.
[25] Manuel Hidalgo,et al. Patient-derived xenograft models: an emerging platform for translational cancer research. , 2014, Cancer discovery.
[26] J. Schmid,et al. The complexity of NF-κB signaling in inflammation and cancer , 2013, Molecular Cancer.
[27] Aik Choon Tan,et al. Patient-derived tumour xenografts as models for oncology drug development , 2012, Nature Reviews Clinical Oncology.
[28] Zhiwei Wang,et al. Targeting Notch signaling pathway to overcome drug resistance for cancer therapy. , 2010, Biochimica et biophysica acta.
[29] Malte Buchholz,et al. Stromal biology and therapy in pancreatic cancer , 2010, Gut.
[30] Y. Muragaki,et al. SNAIL induces epithelial-to-mesenchymal transition in a human pancreatic cancer cell line (BxPC3) and promotes distant metastasis and invasiveness in vivo. , 2010, Experimental and molecular pathology.
[31] V. Keshamouni,et al. Glycogene Expression Alterations Associated with Pancreatic Cancer Epithelial-Mesenchymal Transition in Complementary Model Systems , 2010, PloS one.
[32] J. Kleeff,et al. Tumor microenvironment and progression of pancreatic cancer. , 2010, Experimental oncology.
[33] Z. Madeja,et al. Blood monocytes stimulate migration of human pancreatic carcinoma cells in vitro: the role of tumour necrosis factor - alpha. , 2009, European journal of cell biology.
[34] Huafeng Zhang,et al. Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization , 2009, Proceedings of the National Academy of Sciences.
[35] Zhiwei Wang,et al. Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway. , 2009, Cancer research.
[36] A. Debucquoy,et al. Morphological features and molecular markers in rectal cancer from 95 patients included in the European Organisation for Research and Treatment of Cancer 22921 trial: prognostic value and effects of preoperative radio (chemo) therapy. , 2008, European journal of cancer.
[37] H. Buhr,et al. Epithelial to Mesenchymal Transition: Expression of the Regulators Snail, Slug, and Twist in Pancreatic Cancer , 2007, Clinical Cancer Research.
[38] R. Hruban,et al. An In vivo Platform for Translational Drug Development in Pancreatic Cancer , 2006, Clinical Cancer Research.
[39] Gilles Caraux,et al. PermutMatrix: a graphical environment to arrange gene expression profiles in optimal linear order , 2005, Bioinform..
[40] M. Monden,et al. Prognostic Significance of Activated Akt Expression in Pancreatic Ductal Adenocarcinoma , 2004, Clinical Cancer Research.